Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Announces Second Quarter Results

GlobeNewswire August 14, 2018

Spectral Announces Successful Manufacturing Audit of Toray by the US FDA

GlobeNewswire July 18, 2018

Spectral Announces Voting Results of Annual Meeting

GlobeNewswire June 7, 2018

Spectral Provides Corporate Update

GlobeNewswire May 30, 2018

Spectral Announces First Quarter Results

GlobeNewswire May 11, 2018

Spectral Announces Fourth Quarter and Fiscal 2017 Results

GlobeNewswire March 29, 2018

US Food and Drug Administration (FDA) provides communication to Spectral  

GlobeNewswire March 19, 2018

Spectral Announces Health Canada Approval of Its Proprietary Stand-Alone Pump for CRRT and Hemoperfusion

GlobeNewswire February 15, 2018

Spectral Medical Announces the Appointment of Chief Financial Officer

GlobeNewswire February 1, 2018

FDA Grants 510(k) Clearance for Spectral's Proprietary Stand-Alone Pump

Marketwired December 18, 2017

Spectral to Launch Toraymyxin(TM)/EAA(TM) in Canada in Q1 2018

Marketwired December 13, 2017

Spectral Announces Third Quarter Results

Marketwired November 14, 2017

Spectral Provides Update on FDA Meeting Regarding Its PMA Submission for Toraymyxin(TM)

MarketWire Canada October 31, 2017

Spectral Announces Retirement of Chief Financial Officer

MarketWire Canada October 18, 2017

Spectral Presents Key EUPHRATES Trial Data at the Canadian Critical Care Forum

MarketWire Canada October 4, 2017

Spectral Provides Regulatory Update on Its PMA Submission for Toraymyxin(TM)

MarketWire Canada September 21, 2017

Spectral Announces Second Quarter Results

MarketWire Canada August 11, 2017

FDA Accepts Spectral's PMA for Toraymyxin(TM) for Review

MarketWire Canada July 24, 2017

Spectral's Trial Data to Be Presented at 35th Vicenza Course on AKI and CRRT

MarketWire Canada June 12, 2017

Spectral Announces Voting Results of Annual Meeting

MarketWire Canada June 1, 2017